| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017476 |
| Receipt No. | R000020253 |
| Scientific Title | A feasibility traial of hand exoskeleton robot "Smove" which was designed to support impaired hand grip for post stroke patients in the daily living. |
| Date of disclosure of the study information | 2015/05/09 |
| Last modified on | 2021/05/12 (Ver. 4) |
| Basic information | ||
| Public title | A feasibility traial of hand exoskeleton robot "Smove" which was designed to support impaired hand grip for post stroke patients in the daily living. | |
| Acronym | A feasibility traial of "Smove" | |
| Scientific Title | A feasibility traial of hand exoskeleton robot "Smove" which was designed to support impaired hand grip for post stroke patients in the daily living. | |
| Scientific Title:Acronym | A feasibility traial of "Smove" | |
| Region |
|
|
| Condition | ||||
| Condition | Stroke | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | Investigate the safty and efficacy of the hand exoskeleton robot "Smove" which was designed to support the daily living of post CVD patients who have impaired uppuer limb movement. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The normaloperation of "Smove" on patients.
The sefety of "Smove" on patients. The improvement in the hand grip or pinch strength of the patients. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Wear the hand exoskeleton device "Smove" for maximum 1 hour. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Stroke survivor (over 5 days after onset) who has paresis in his or her upper limb.
Who is over 20 years old age. Who can communicate properly. Whose recovery stage is Brunnstrom stage=> III in the arm Brunnstrom stage=> II in the hand Who can smoothly wear the "Smove" by himself or by caregiver. Who can make informed concent properly. (If the patient can't sign on the agreement document, a witness confirm the patient's agreement orally and sign on the agreement document on behalf of the patient) |
|||
| Key exclusion criteria | The patient whose condition is not suitable for recieving rehabilitation thearapy.
e.g. JCS =>10, SBP>180, DBP<80, HR >120/min Body temperature=> 38.0 degree Celsius. The patient who has strong pain in his impaired limb who has strong spascity (Ashworth =>3) who is recieving some therapy for spascity. The patient who has other serious condition or allergy. |
|||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Faculty of medical sciences, Kyushu University | ||||||
| Division name | Department of Advanced Medical Initiatives | ||||||
| Zip code | |||||||
| Address | 3-1-1 Maidashi, Higasi-ku, Fukuoka City, Fukuoka, Japan | ||||||
| TEL | 092-642-5592 | ||||||
| mhashi@dem.med.kyushu-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Faculty of medical sciences, Kyushu University | ||||||
| Division name | Neurosurgery | ||||||
| Zip code | |||||||
| Address | 3-1-1 Maidashi, Higasi-ku, Fukuoka City, Fukuoka, Japan | ||||||
| TEL | 092-642-5524 | ||||||
| Homepage URL | |||||||
| mukae@ns.med.kyushu-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kyushu University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Science and Technology Agency |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020253 |